Search for: [Abstract = "Aortic stenosis \(AS\) is the most frequent acquired valve disease indeveloped countries. The prevalence of AS in the elderly \(>75 yearsold\) is 12.4% of whom 3.4% have severe AS. Severe symptomatic ASis associated with a poor prognosis, as most patients die within 2–3years of diagnosis. Aortic valve replacement \(AVR\) is the preferred treatment of symptomatic AS but unavailable for many patients due to high procedural risk. Transcatheter aortic valve implantation \(TAVI\)and balloon aortic valve valvuloplasty \(BAV\) are less invasiveprocedures as compared to surgery. TAVI is now given particularprominence in the group of high\-risk patients as an acceptablealternative to AVR, with reported improvement in the quality of lifeand clinical outcomes. According to the European Society ofCardiology \(ESC\) guidelines for the management of valvular heart disease, BAV may be considered as a bridge to surgery or TAVI inhaemodynamically unstable patients who are at high risk for surgery,or in patients with symptomatic severe AS who require urgent major non\-cardiac surgery \(Class IIb, Level C\). BAV may also be consideredas a palliative procedure in selected cases when both surgery andTAVI are contraindicated because of severe comorbidities. BAV maybe especially beneficial in those patients leading to temporaryimprovement of LVEF and requalification to TAVI\/AVR. Etiology of degenerative AS reveals s"]

Number of results: 1